VBI Vaccines Announces Development of a Novel Glioblastoma Immunotherapy Candidate
October 08, 2015 at 08:04 AM EDT
VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI") today announced that it has applied its eVLP Platform in the development of a novel therapeutic ...